Vanessa Dumeaux

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi request reprint Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study
    Vanessa Dumeaux
    University of Tromsø, Institute of Community Medicine, Tromsø, Norway
    Int J Cancer 105:844-50. 2003
  2. ncbi request reprint Use of oral contraceptives, alcohol, and risk for invasive breast cancer
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, Norway
    Cancer Epidemiol Biomarkers Prev 13:1302-7. 2004
  3. ncbi request reprint Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    Mol Cancer Ther 5:868-76. 2006
  4. pmc Sex hormones and gene expression signatures in peripheral blood from postmenopausal women - the NOWAC postgenome study
    Marit Waaseth
    Department of Community Medicine, University of Tromsø, Tromsø, Norway
    BMC Med Genomics 4:29. 2011
  5. doi request reprint Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition
    Kjersti Bakken
    Department of Community Medicine, University of Tromsø, Tromsø, Norway
    Int J Cancer 128:144-56. 2011
  6. ncbi request reprint Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft
    Eiliv Lund
    Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway
    Int J Epidemiol 37:36-41. 2008
  7. pmc Deciphering normal blood gene expression variation--The NOWAC postgenome study
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    PLoS Genet 6:e1000873. 2010
  8. pmc Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway
    Breast Cancer Res 10:R13. 2008
  9. ncbi request reprint Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study
    Eiliv Lund
    Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    Int J Cancer 121:645-8. 2007
  10. pmc Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis
    Marit Waaseth
    Institute of Community Medicine, University of Tromsø, Norway
    BMC Womens Health 8:1. 2008

Detail Information

Publications15

  1. ncbi request reprint Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study
    Vanessa Dumeaux
    University of Tromsø, Institute of Community Medicine, Tromsø, Norway
    Int J Cancer 105:844-50. 2003
    ..002). In conclusion, the increased risk of breast cancer related with OC formulations could be due mostly to estrogen component...
  2. ncbi request reprint Use of oral contraceptives, alcohol, and risk for invasive breast cancer
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, Norway
    Cancer Epidemiol Biomarkers Prev 13:1302-7. 2004
    ..Whether the interactive effect differs according to menopausal status remains unclear and needs further investigations...
  3. ncbi request reprint Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    Mol Cancer Ther 5:868-76. 2006
    ..g., receptor and transporter activities, immune response, frizzled signaling pathway, actin filament organization, and glycogen metabolism)...
  4. pmc Sex hormones and gene expression signatures in peripheral blood from postmenopausal women - the NOWAC postgenome study
    Marit Waaseth
    Department of Community Medicine, University of Tromsø, Tromsø, Norway
    BMC Med Genomics 4:29. 2011
    ..Our objective was to explore potential associations between sex hormones and gene expression in whole blood from a population-based, random sample of postmenopausal women..
  5. doi request reprint Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition
    Kjersti Bakken
    Department of Community Medicine, University of Tromsø, Tromsø, Norway
    Int J Cancer 128:144-56. 2011
    ..Continuous combined preparations were associated with the highest risk. Further studies are needed to disentangle the effects of the regimen and the progestin component...
  6. ncbi request reprint Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft
    Eiliv Lund
    Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway
    Int J Epidemiol 37:36-41. 2008
  7. pmc Deciphering normal blood gene expression variation--The NOWAC postgenome study
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    PLoS Genet 6:e1000873. 2010
    ....
  8. pmc Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway
    Breast Cancer Res 10:R13. 2008
    ..The introduction of high-throughput technologies, also called -omics technologies, into epidemiology has raised the need for high-quality observational studies to reduce several sources of error and bias...
  9. ncbi request reprint Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study
    Eiliv Lund
    Institute of Community Medicine, University of Tromsø, Tromsø, Norway
    Int J Cancer 121:645-8. 2007
    ....
  10. pmc Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis
    Marit Waaseth
    Institute of Community Medicine, University of Tromsø, Norway
    BMC Womens Health 8:1. 2008
    ..A secondary objective was to validate self-reported questionnaire information on menstruation and HRT use in the Norwegian Women and Cancer postgenome cohort (NOWAC)...
  11. pmc Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
    Vanessa Dumeaux
    Institute of Community Medicine, University of Tromsø, France
    Cancer Causes Control 16:537-44. 2005
    ..To assess postmenopausal breast cancer risk in relation to particular patterns of oral contraceptive (OC) use according to hormone replacement therapy (HRT) exposure...
  12. doi request reprint Systems epidemiology in cancer
    Eiliv Lund
    Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway
    Cancer Epidemiol Biomarkers Prev 17:2954-7. 2008
    ..Systems epidemiology with a focus on gene functions challenges the current concept of biobanking, which focuses mainly on DNA analyses...
  13. ncbi request reprint Comparison of globin RNA processing methods for genome-wide transcriptome analysis from whole blood
    Vanessa Dumeaux
    , Institute of Community Medicine, Norway
    Biomark Med 2:11-21. 2008
    ..In our study, globin reduction was not found to be beneficial using the Applied Biosystems microarray system (AB1700)...
  14. pmc Towards a more functional concept of causality in cancer research
    Eiliv Lund
    Institute of Community Medicine, University of Tromsø 9037 Tromsø, Norway
    Int J Mol Epidemiol Genet 1:124-33. 2010
    ..The use of gene expression profiles and epigenetics could produce a functional concept of causality to explain the human multistage carcinogenic process...
  15. pmc TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
    Pedro Kringen
    Department of Genetics, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
    BMC Cancer 5:134. 2005
    ..We analyzed differences in relation to BRCA1 germline status, TP53 status, survival and age at diagnosis, as previous studies have not been conclusive...